SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Invest / LTD

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bw who wrote (7945)3/25/1999 5:18:00 PM
From: Thean  Read Replies (2) of 14427
 
bw, try to hold DRMD if you can. Volatility near term is to be expected. But today's news is one that transforms a small generic into a brand name company overnight. There are just too many positive things waiting to happen, like their announcement of their marketing partner (too bad it's not PFE it looks like - they hinted a Fortune 200 company), their next combo therapy phase III trial result, further ANDA approval in the next few months. Positive speculation will keep the stock in healthy condition.

Based on your response on INHL, I believe neither you nor anyone in the family is a diabetic. INHL's next big thing is to submit their insulin powder inhalation therapy and they have PFE as their marketing partner. If you think DRMD's show today was exciting, wait till the day INHL gets their approval. This one is very big but approval will be at least 1 year away. Still good for trades - look at their chart. If you happen to drive around their Palo Alto facility next time you take your clients out for a spin around that area, please update me on the impression INHL's building and locale makes upon you. TIA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext